Cite Filings / PRLD / 0001104659-25-108459

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Prelude Therapeutics Inc Filed 2025-11-07 Acc 0001104659-25-108459

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-04-28 SCHEDULE 13G Statement of Beneficial Ownership
2025-11-12 10-Q Quarterly Report
2025-11-12 8-K Results of operations · Regulation FD disclosure
2025-11-07 4 Options or other derivatives
2025-11-07 SCHEDULE 13G Statement of Beneficial Ownership
2025-11-04 8-K Material agreement · Unregistered share sale · Executive or director change · Regulation FD disclosure

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…